Intestinal Dysbiosis Correlates With Sirolimus-induced Metabolic Disorders in Mice

Abstract

Our study demonstrated a potentially causative role of intestinal dysbiosis in sirolimus-induced metabolic disorders, which will provide a novel therapeutic target for transplant recipients.